JP2001139945A - Antioxidant - Google Patents

Antioxidant

Info

Publication number
JP2001139945A
JP2001139945A JP32796699A JP32796699A JP2001139945A JP 2001139945 A JP2001139945 A JP 2001139945A JP 32796699 A JP32796699 A JP 32796699A JP 32796699 A JP32796699 A JP 32796699A JP 2001139945 A JP2001139945 A JP 2001139945A
Authority
JP
Japan
Prior art keywords
extract
antioxidant
dimethyl ether
extraction
foods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP32796699A
Other languages
Japanese (ja)
Inventor
Kazunari Miyata
和成 宮田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Kasei Corp
Original Assignee
Asahi Kasei Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Kasei Corp filed Critical Asahi Kasei Corp
Priority to JP32796699A priority Critical patent/JP2001139945A/en
Publication of JP2001139945A publication Critical patent/JP2001139945A/en
Withdrawn legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To obtain a natural antioxidant usable as a material for medicines, foods, cosmetics, and the like. SOLUTION: This antioxidant is obtained by including a solvent-extract from a plant belonging to Lardizabalaceae. The antioxidant extracted from Akebia quinata Decne is originated from a natural product and has excellent antioxidant property. So it can be applied not only to prevent oxidation of foods, or the like, but also to obtain medicines, foods, cosmetics aiming at the prevention of arteriosclerosis caused by lipid oxidation and the prevention of skin aging, or the like.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、医薬、食品、化粧
品素材として利用可能な、天然物由来の抗酸化剤に関す
る。
[0001] The present invention relates to a natural product-derived antioxidant which can be used as a pharmaceutical, food or cosmetic material.

【0002】[0002]

【従来の技術】従来より、フリーラジカルや活性酸素は
生体組織に有毒な毒性を有するとされていたが、特に近
年の研究により、フリーラジカルや活性酸素により生体
が障害され、さまざまな疾病や発癌、あるいは老化にも
関連していることが明かとなってきた。また同時に、野
菜や果物などの植物には、「抗酸化成分」が比較的多く
含まれており、食品として摂取した抗酸化物質が、ヒト
の体内でフリーラジカルや活性酸素の消去に役立ってい
ると考えられるようになってきた。そこで、天然物から
抽出された抗酸化能を有する物質の作用機序を明らかに
し、医薬品、食品、化粧品等に応用しようとして開発が
進められている。
2. Description of the Related Art Conventionally, free radicals and active oxygen have been considered to have toxic toxicity to living tissues. In particular, recent research has shown that free radicals and active oxygen can damage living bodies, causing various diseases and carcinogenesis. Or aging. At the same time, plants such as vegetables and fruits contain a relatively large amount of "antioxidant components", and antioxidants ingested as food help to eliminate free radicals and active oxygen in the human body It has come to be considered. Therefore, the mechanism of action of a substance having an antioxidant ability extracted from a natural product has been clarified, and development has been pursued for application to medicines, foods, cosmetics, and the like.

【0003】本発明が対象としているアケビ科植物にお
いては、その抽出物の抗酸化剤への応用は知られていな
い。アケビの茎は、生薬名「モクツウ(木通)」と呼ば
れ、消炎、利尿に効き目があるとされ、その水抽出物が
利用されてきた。アケビの有機溶剤抽出物を利用した例
としては、サポニン成分を経口投与された薬理活性物質
の吸収を補助するための経口投与用薬物吸収補助剤とし
て利用するもの(特開昭57−145816)、ヘデラ
ゲニンを含む抽出物を必須成分として、美白効果、シミ
防止効果、抗炎症効果に優れた化粧料組成物を提供する
もの(特開昭64−42411)、ヘデラゲニンを含む
抽出物を必須成分として、抗炎症効果に優れた歯ミガキ
組成物を提供するもの(特開平2−262510)、ト
リテルペン配糖体を有効成分として含有する制ガン剤を
提供するもの(特開昭60−8224)等がある。この
ようにアケビの抽出物は、抗炎症作用、利尿作用、美白
作用等に利用されているにすぎない。
[0003] In the Akebiaceae plant to which the present invention is applied, the application of the extract to an antioxidant is not known. The stalk of akebi is called herbal medicine name "Mokutsu (Kidori)", and is said to be effective for inflammation and diuresis, and its water extract has been used. Examples of the use of the organic solvent extract of akebi include those in which a saponin component is used as a drug absorption aid for oral administration for assisting absorption of an orally administered pharmacologically active substance (Japanese Patent Application Laid-Open No. 57-145816). An extract containing hederagenin as an essential component, which provides a cosmetic composition having an excellent whitening effect, an anti-stain effect, and an anti-inflammatory effect (JP-A-64-42411), an extract containing hederagenin as an essential component, There are those which provide a toothpaste composition having an excellent anti-inflammatory effect (JP-A-2-262510) and those which provide an anticancer agent containing a triterpene glycoside as an active ingredient (JP-A-60-8224). Thus, the extract of akebi is only used for anti-inflammatory action, diuretic action, whitening action and the like.

【0004】[0004]

【発明が解決しようとする課題】本発明は、医薬品、食
品、化粧品等の素材として利用可能な、天然物由来の抗
酸化剤を提供することを目的とする。
SUMMARY OF THE INVENTION An object of the present invention is to provide an antioxidant derived from a natural product which can be used as a material for pharmaceuticals, foods, cosmetics and the like.

【0005】[0005]

【課題を解決するための手段】本発明者は、古くより人
体に対して用いられ、安全性上問題の少ないと考えられ
る野菜および生薬類について、その抽出物の抗酸化活性
を鋭意検討したところ、驚くべきことに、アケビの有機
溶媒抽出物に高い抗酸化活性があることを見出し、本発
明を完成するに至った。すなわち、本発明は、アケビ科
植物の抽出物を含有することを特徴とする抗酸化剤であ
る。この際、アケビ科植物はアケビ(Akebia quinata D
ecne)またはその同属植物(アケビ科アケビ属)が好ま
しく、また、アケビ科植物の使用部位は果実が好まし
く、抽出に用いる溶媒は、ジメチルエーテルが特に好ま
しい。
The present inventors have conducted intensive studies on the antioxidant activity of extracts of vegetables and herbal medicines which have been used for the human body for a long time and are considered to have few problems in safety. Surprisingly, the present inventors have found that the organic solvent extract of akebi has a high antioxidant activity, and completed the present invention. That is, the present invention is an antioxidant characterized by containing an extract of a plant of the family Akebiaceae. At this time, the Akebiaceae plant is Akebia (Akebia quinata D
ecne) or a congener thereof (Akebiaceae: Akebiaceae) is preferable, and the site of the Akebiaceae plant is preferably a fruit, and the solvent used for extraction is particularly preferably dimethyl ether.

【0006】本発明の抽出原料としてのアケビ科植物に
は、アケビ属(Akebia)またはムベ属(Stauntonia)が
ある。アケビ属に属する種には、アケビ(Akebia quina
ta Decne)、ミツバアケビ(Akebia trifoliata Koizdu
mi)、ゴヨウアケビ(Akebiapentaphylla Makino )等
があり、ムベ属に属する種にはムベ(Stauntonia hexap
hylla Decne )等がある。使用部位は、果実(果皮、果
肉、種子等)、茎、根、葉等いずれの部位を用いてもか
まわない。好適には、アケビ(Akebi quinataDecne
)、もしくはその同属植物であるミツバアケビ、ゴヨ
ウアケビ等の果皮、もしくは種子を含んだ果実が使用で
きる。
[0006] Examples of the Akebiaceae plants used as the extraction raw material of the present invention include Akebia and Stauntonia. Species belonging to the genus Akebia include Akebia (Akebia quina
ta Decne), Akebia trifoliata Koizdu
mi), Akebia pentaphylla Makino, and other species belonging to the genus Mbe.
hylla Decne). The site to be used may be any site such as fruit (peel, pulp, seed, etc.), stem, root, leaf, etc. Preferably, the akebi (Akebi quinataDecne)
) Or its congener plants, such as honeysuckle and sycamore, or the fruit containing seeds.

【0007】抽出溶媒の種類としては、特に限定されな
いが、メタノール、エタノール、プロパノール、イソプ
ロパノール、ブタノールおよびイソブタノール等のアル
コール系溶剤、ジメチルエーテル、ジエチルエーテルお
よびメチルエチルエーテル等のエーテル系溶剤、酢酸エ
チル、酢酸ブチルおよびプロピオン酸エチル等のエステ
ル系溶剤、アセトン等のケトン系溶剤、クロロホルム、
ジクロロメタン等の塩素系溶剤等の極性溶剤が挙げら
れ、これらを単独または2種以上を混合して、もしくは
水を混合して使用できる。好ましくは、人体への安全性
が高く、食品製造に一般に使用されているエタノール、
もしくは溶剤の残留のおそれがないジメチルエーテルが
選択される。特に、高い抗酸化活性の抽出物が得られる
点からジメチルエーテルが好適である。
[0007] The type of the extraction solvent is not particularly limited, but alcoholic solvents such as methanol, ethanol, propanol, isopropanol, butanol and isobutanol; ether solvents such as dimethyl ether, diethyl ether and methyl ethyl ether; Ester solvents such as butyl acetate and ethyl propionate, ketone solvents such as acetone, chloroform,
Examples thereof include polar solvents such as a chlorine-based solvent such as dichloromethane, and these can be used alone or as a mixture of two or more kinds, or mixed with water. Preferably, ethanol which is highly safe for the human body and is generally used for food production,
Alternatively, dimethyl ether which does not cause the solvent to remain is selected. Particularly, dimethyl ether is preferred because an extract having high antioxidant activity can be obtained.

【0008】抽出操作は常法による。すなわち、粉砕し
た原料1重量部(乾燥重量)に対して抽出溶媒5〜20
倍量を添加して実施される。原料は、生でも乾燥物でも
かまわない。抽出は、一般に常温付近である10〜40
℃で、30分〜2時間実施される。抽出後、抽出残渣を
ろ過もしくは遠心分離等の分離操作により分離し、抽出
ろ液を得る。また、ソックスレー型の抽出器を用いるこ
ともできる。この抽出ろ液を濃縮し、抽出物を得る。抗
酸化活性を高めるために、溶剤分画やカラム分画等の一
般的な方法により精製することができる。得られた精製
物から溶媒を蒸発乾固(凍結乾燥、噴霧乾燥等)するこ
とで、目的とする抗酸化剤を得ることができる。好まし
くは低温で、しかも、酸素との接触の少ない条件で乾燥
できる凍結乾燥が望ましい。また、蒸発乾燥の過程で、
結晶セルロース、デンプン、乳糖等の賦形剤等を混合し
ておくこともできる。
[0008] The extraction operation is performed by a conventional method. That is, 5 parts to 20 parts of the extraction solvent is used for 1 part by weight (dry weight) of the pulverized raw material.
It is performed by adding a double volume. Raw materials may be raw or dried. The extraction is generally performed at around room temperature of 10 to 40.
C. for 30 minutes to 2 hours. After extraction, the extraction residue is separated by a separation operation such as filtration or centrifugation to obtain an extraction filtrate. Also, a Soxhlet extractor can be used. The extract filtrate is concentrated to obtain an extract. In order to increase the antioxidant activity, purification can be performed by a general method such as solvent fractionation or column fractionation. The target antioxidant can be obtained by evaporating the solvent from the obtained purified product to dryness (freeze drying, spray drying, etc.). Freeze-drying, which can be dried preferably at low temperature and under conditions of low contact with oxygen, is desirable. In the process of evaporative drying,
Excipients such as crystalline cellulose, starch, and lactose can also be mixed.

【0009】こうして得られたアケビの抽出物は、天然
物由来で優れた抗酸化活性を有しているので、フリーラ
ジカルや活性酸素に起因すると考えられている疾病の予
防、例えば、大腸癌等の発癌、心筋梗塞や虚血性心疾患
等の動脈硬化性疾患、パーキンソン病やアルツハイマー
等の神経性疾患、さらには、眼疾患、腎疾患等の予防効
果が期待できる。また、脂質酸化に起因する皮膚の老化
防止等の効果も期待できる。すなわち、本発明の抗酸化
剤は、食品等の酸化防止だけでなく、脂質酸化に起因す
る動脈硬化や皮膚の老化等の防止目的で、医薬品、食
品、化粧品等に利用できる。また、本発明の抗酸化剤
は、ビタミンE、ビタミンC、甘草等の他の植物抽出
物、BHT等の他の抗酸化剤との併用も可能である。
The thus-obtained akebi extract has excellent antioxidant activity derived from natural products, and thus prevents diseases considered to be caused by free radicals or active oxygen, such as colon cancer. Can be expected to prevent carcinogenesis, arteriosclerotic diseases such as myocardial infarction and ischemic heart disease, neurological diseases such as Parkinson's disease and Alzheimer's disease, as well as eye diseases and kidney diseases. In addition, effects such as prevention of skin aging caused by lipid oxidation can be expected. That is, the antioxidant of the present invention can be used in medicines, foods, cosmetics, and the like for the purpose of preventing not only oxidation of foods and the like but also arteriosclerosis and skin aging caused by lipid oxidation. The antioxidant of the present invention can be used in combination with other plant extracts such as vitamin E, vitamin C, licorice, and other antioxidants such as BHT.

【0010】[0010]

【発明の実施の形態】以下、実験例、実施例および応用
例により、さらに詳しく本発明の説明を行うが、これら
実施例は、なんら本発明を限定するものではない。
BEST MODE FOR CARRYING OUT THE INVENTION Hereinafter, the present invention will be described in more detail with reference to experimental examples, examples, and application examples, but these examples do not limit the present invention in any way.

【実験例1】アケビの実を水、ヘキサン、エタノール、
ジメチルエーテルで抽出し、各抽出物の抗酸化活性を比
較した。抽出原料は、アケビの実の乾燥物(水分9%)
を5mm以下程度に粉砕したものを用いた。ジメチルエ
ーテル抽出は、原料200gを撹拌機付き5L耐圧容器
に入れ、ジメチルエーテル3000mlを圧入後、30
℃下30分間撹拌抽出を行った後、燒結金属によりろ別
し、別の耐圧容器に受け入れた。このろ別した抽出液を
30℃下で、ジメチルエーテルを蒸発させた。この濃縮
液を、一昼夜室温にて凍結乾燥することにより、抽出物
10.3gを得た。水抽出、ヘキサン抽出およびエタノ
ール抽出は、それぞれ原料200gを撹拌機付き5L耐
圧容器に入れ溶剤3000mLを加え、30℃下30分
間撹拌抽出を行った後、メンブレンフィルター(孔径
0.2μ)によりろ別し、抽出ろ液を回収した。抽出ろ
液をエバポレータで真空濃縮後、一昼夜室温にて凍結乾
燥することにより、抽出物各々59.9g、1.4gお
よび15.0gを得た。
[Experimental example 1] Akebia berries were mixed with water, hexane, ethanol,
Extraction was performed with dimethyl ether, and the antioxidant activity of each extract was compared. The raw material for the extraction is dried akebi (9% moisture)
Obtained by pulverizing to about 5 mm or less. For dimethyl ether extraction, 200 g of the raw material was placed in a 5 L pressure vessel equipped with a stirrer, and after 3,000 ml of dimethyl ether was injected, 30 g of dimethyl ether was added.
After performing stirring extraction at 30 ° C. for 30 minutes, the mixture was filtered with a sintered metal and received in another pressure vessel. Dimethyl ether was evaporated from the filtered extract at 30 ° C. This concentrated liquid was freeze-dried at room temperature for 24 hours to obtain 10.3 g of an extract. For water extraction, hexane extraction and ethanol extraction, 200 g of each raw material was placed in a 5 L pressure vessel equipped with a stirrer, 3,000 mL of a solvent was added, and the mixture was stirred and extracted at 30 ° C. for 30 minutes, and then filtered through a membrane filter (pore size 0.2 μm). Then, the extraction filtrate was recovered. The extract filtrate was concentrated in vacuo using an evaporator, and then freeze-dried at room temperature for 24 hours to obtain 59.9 g, 1.4 g and 15.0 g of the extract, respectively.

【0011】抗酸化活性の測定は、基準油脂分析試験法
(日本油化学会編)の「参2.5−1996 自動酸化
に対する安定性試験 オーブン試験(重量法)」に準じ
た以下の方法により行った。抽出物50mgをリノール
酸試薬5gに加え、真空下60℃にて30分間撹拌混合
し均一にした。この液1gをペトリ皿(直系3.5c
m)に正確に計り、55℃のオーブン中での重量増加を
経時的に測定した。重量の測定は1日に1回行い、重量
増加率が0.5%に達した時間を試料の酸化時間とし
た。別に組成物を添加しないリノール酸液も同様に処理
し、ブランクの酸化時間とした。試料の抗酸化活性は、
試料の酸化時間からブランクの酸化時間を減じた時間と
した。抗酸化活性の測定結果を、表1に示した。水およ
びヘキサンによる抽出では、ほとんど抗酸化活性は認め
られず、エタノールおよびジメチルエーテルの極性溶媒
で高い抗酸化活性を有する抽出物が得られた。特にジメ
チルエーテルによる抽出物に高い抗酸化活性が認められ
た。
The antioxidant activity is measured by the following method according to "Reference 2.5-1996 Stability test for autoxidation, oven test (gravimetric method)" of the standard fat and oil analysis test method (edited by the Japan Oil Chemists' Society). went. 50 mg of the extract was added to 5 g of the linoleic acid reagent, and the mixture was stirred and mixed at 60 ° C. for 30 minutes under vacuum to make it uniform. 1 g of this liquid is placed in a Petri dish (3.5 c
m) was accurately measured and the weight increase in an oven at 55 ° C. was measured over time. The weight was measured once a day, and the time when the rate of weight increase reached 0.5% was defined as the oxidation time of the sample. Separately, a linoleic acid solution to which no composition was added was treated in the same manner, and the blank oxidation time was set. The antioxidant activity of the sample
The time was obtained by subtracting the oxidation time of the blank from the oxidation time of the sample. Table 1 shows the measurement results of the antioxidant activity. Extraction with water and hexane showed almost no antioxidant activity, and an extract having high antioxidant activity was obtained with polar solvents of ethanol and dimethyl ether. In particular, an extract with dimethyl ether showed high antioxidant activity.

【0012】[0012]

【表1】 [Table 1]

【0013】以下の実施例は、アケビの実の乾燥物(水
分9%)を5mm以下程度に粉砕したものを用いた。
In the following examples, a dried product of Akebi (9% moisture) was ground to about 5 mm or less.

【実施例1】原料200gおよび水150mlを撹拌機
付き5L耐圧容器に入れ、ジメチルエーテル3000m
lを圧入後、30℃下30分間撹拌抽出を行った後、メ
ンブレンフィルター(孔径0.2μ)によりろ別し、別
の耐圧容器に受け入れた。このろ別した抽出液を30℃
下で、ジメチルエーテルを蒸発させた。この濃縮液を一
昼夜室温にて凍結乾燥することにより、粘土状の抽出物
15.0gを得た。この抽出物の実験例1で示される抗
酸化活性は、180hであった。
Example 1 200 g of raw materials and 150 ml of water were placed in a 5 L pressure vessel equipped with a stirrer, and dimethyl ether 3000 m
After pressurized injection, the mixture was stirred and extracted at 30 ° C. for 30 minutes, filtered off with a membrane filter (pore size 0.2 μm), and received in another pressure vessel. The extract separated by filtration is 30 ° C.
Under, the dimethyl ether was evaporated. This concentrated liquid was freeze-dried at room temperature for 24 hours to obtain 15.0 g of a clay-like extract. The antioxidant activity of this extract shown in Experimental Example 1 was 180 hours.

【0014】[0014]

【実施例2】原料200gおよび水150mlを撹拌機
付き5L耐圧容器に入れ、ジメチルエーテル3000m
lを圧入後、30℃下30分間撹拌抽出を行った後、メ
ンブレンフィルター(孔径0.2μ)によりろ別し、別
の耐圧容器に受け入れた。このろ別した抽出液を30℃
下で、ジメチルエーテルを蒸発させ、500mlまで濃
縮した。この濃縮液を静置し、二相に分離させた後、水
層を除去した。得られたジメチルエーテル相を減圧下濃
縮後、一昼夜室温にて凍結乾燥することにより、粉末状
の抽出物6.3gを得た。この抽出物の実験例1で示さ
れる抗酸化活性は、315hであった。
Example 2 200 g of raw materials and 150 ml of water were put into a 5 L pressure vessel equipped with a stirrer, and dimethyl ether 3000 m
After pressurized injection, the mixture was stirred and extracted at 30 ° C. for 30 minutes, filtered off with a membrane filter (pore size 0.2 μm), and received in another pressure vessel. The extract separated by filtration is 30 ° C.
Under, the dimethyl ether was evaporated and concentrated to 500 ml. After leaving this concentrated liquid to separate into two phases, the aqueous layer was removed. The obtained dimethyl ether phase was concentrated under reduced pressure, and freeze-dried at room temperature for 24 hours to obtain 6.3 g of a powdery extract. The antioxidant activity of this extract shown in Experimental Example 1 was 315 h.

【0015】[0015]

【実施例3】原料200gおよび水150mlを撹拌機
付き5L耐圧容器に入れ、ジメチルエーテル3000m
lを圧入後、30℃下30分間撹拌抽出を行った後、メ
ンブレンフィルター(孔径0.2μ)によりろ別し、別
の耐圧容器に受け入れた。このろ別した抽出液を30℃
下で、ジメチルエーテルを蒸発させ、500mlまで濃
縮した。この濃縮液を静置し、二相に分離させた後、水
層を除去した。残ったジメチルエーテル層に水100m
lを圧入し、混合した後、静置し、二相に分離させた。
再び水層を除去し、得られたジメチルエーテル相を減圧
下濃縮後、一昼夜室温にて凍結乾燥することにより、粉
末状の抽出物5.4gを得た。この抽出物の実験例1で
示される抗酸化活性は、497hであった。
Example 3 200 g of raw materials and 150 ml of water were placed in a 5 L pressure vessel equipped with a stirrer, and dimethyl ether 3000 m
After pressurized injection, the mixture was stirred and extracted at 30 ° C. for 30 minutes, filtered off with a membrane filter (pore size 0.2 μm), and received in another pressure vessel. The extract separated by filtration is 30 ° C.
Under, the dimethyl ether was evaporated and concentrated to 500 ml. After leaving this concentrated liquid to separate into two phases, the aqueous layer was removed. 100 m of water in the remaining dimethyl ether layer
After press-fitting and mixing, the mixture was allowed to stand and separated into two phases.
The aqueous layer was removed again, and the obtained dimethyl ether phase was concentrated under reduced pressure and freeze-dried at room temperature for 24 hours to obtain 5.4 g of a powdery extract. The antioxidant activity of this extract shown in Experimental Example 1 was 497 h.

【0016】[0016]

【応用例1】 健康食品 実施例3と同様の方法で得られた抽出物を、固形分濃度
が10重量%となるようにエタノールに溶解した。次い
で、この溶液30重量部を結晶セルロース(アビセル<
登録商標>FD−101、旭化成工業(株)製)30重
量部に加えて良く混合した後、乾燥した。この粉末33
重量部(抽出物3重量部、結晶セルロース30重量部を
含有)とエリスリトール(日研化学(株)製)35重量
部、マルチトール(東和化成工業(株)製)30重量
部、ショ糖脂肪酸エステル(DKエステルF−20W、
第一工業製薬(株)製)2重量部を良く混合した後、ロ
ータリー打錠機((株)菊水製作所製、CLEANPR
ESS CORRECT 12HUK)で8mmφ、1
2Rの杵を用いて、ターンテーブル回転速度12rpm
で打錠し、重量200mgの錠剤を得た。
[Application Example 1] Health food An extract obtained in the same manner as in Example 3 was dissolved in ethanol so that the solid content concentration was 10% by weight. Next, 30 parts by weight of this solution was added to crystalline cellulose (Avicel <
(Registered trademark> FD-101, manufactured by Asahi Kasei Kogyo Co., Ltd.) and mixed well, followed by drying. This powder 33
Parts by weight (containing 3 parts by weight of extract and 30 parts by weight of crystalline cellulose), 35 parts by weight of erythritol (manufactured by Niken Kagaku Co., Ltd.), 30 parts by weight of maltitol (manufactured by Towa Chemical Industry Co., Ltd.), sucrose fatty acid Esters (DK ester F-20W,
After 2 parts by weight of Daiichi Kogyo Seiyaku Co., Ltd.) were mixed well, a rotary tableting machine (Kikusui Seisakusho, CLEANPR)
8mmφ in ESS CORRECT 12HUK), 1
Using a 2R punch, turntable rotation speed 12 rpm
To give a tablet weighing 200 mg.

【0017】[0017]

【応用例2】 化粧料 (油相)ステアリン酸 16.0% 実施例3と同様の方法で得られた抽出物 0.2% 粉末卵黄油(リン脂質30%) 4.0% P.O.E.(20)ソルビタンステアレート 1.0% (水相)プロピレングリコール 10.0% 水 68.0% メチルパラベン 0.1% 油相成分を70℃に保ち、よく溶解混和させ、その中に
70℃に保った水相を滴下混合し、同時にホモミキサー
にて均一に乳化した。乳化後、冷却しながら撹拌をつづ
け、30℃になったならばコロイドミル処理をし、クリ
ームを得た。
[Application Example 2] Cosmetic (oil phase) stearic acid 16.0% Extract obtained in the same manner as in Example 3 0.2% Powdered egg yolk oil (phospholipid 30%) 4.0% POE (20 ) Sorbitan stearate 1.0% (aqueous phase) Propylene glycol 10.0% Water 68.0% Methyl paraben 0.1% Oil phase components were kept at 70 ° C, well dissolved and mixed, and kept at 70 ° C therein. The aqueous phase was dropped and mixed, and simultaneously emulsified uniformly with a homomixer. After emulsification, stirring was continued while cooling, and when the temperature reached 30 ° C, a colloid mill treatment was performed to obtain a cream.

【0018】[0018]

【発明の効果】本発明のアケビから抽出された抗酸化剤
は、天然物由来で優れた抗酸化活性を有しているので、
食品等の酸化防止だけでなく、脂質酸化に起因する動脈
硬化や皮膚の老化等の防止目的で、医薬品、食品、化粧
品等に利用できる。
The antioxidant extracted from the akebi of the present invention has excellent antioxidant activity derived from natural products.
It can be used for medicines, foods, cosmetics, etc. for the purpose of preventing oxidation of foods and the like, as well as for preventing arteriosclerosis and skin aging caused by lipid oxidation.

Claims (4)

【特許請求の範囲】[Claims] 【請求項1】 アケビ科植物の抽出物を含有することを
特徴とする抗酸化剤。
1. An antioxidant comprising an extract of a plant of the family Akebiaceae.
【請求項2】 アケビ科植物が、アケビ(Akebia quina
ta Decne)またはその同属植物(アケビ科アケビ属)で
ある請求項1に記載の抗酸化剤。
2. The plant of the family Akebia is Akebia quina.
The antioxidant according to claim 1, which is a plant of the same genus (Acebiaceae).
【請求項3】 アケビ科植物の使用部位が、果実である
請求項1または2に記載の抗酸化剤。
3. The antioxidant according to claim 1, wherein the site of the Akebiaceae plant is a fruit.
【請求項4】 抽出に用いる溶媒が、ジメチルエーテル
である請求項1ないし3のいずれかに記載の抗酸化剤。
4. The antioxidant according to claim 1, wherein the solvent used for the extraction is dimethyl ether.
JP32796699A 1999-11-18 1999-11-18 Antioxidant Withdrawn JP2001139945A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP32796699A JP2001139945A (en) 1999-11-18 1999-11-18 Antioxidant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP32796699A JP2001139945A (en) 1999-11-18 1999-11-18 Antioxidant

Publications (1)

Publication Number Publication Date
JP2001139945A true JP2001139945A (en) 2001-05-22

Family

ID=18205009

Family Applications (1)

Application Number Title Priority Date Filing Date
JP32796699A Withdrawn JP2001139945A (en) 1999-11-18 1999-11-18 Antioxidant

Country Status (1)

Country Link
JP (1) JP2001139945A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008156509A (en) * 2006-12-25 2008-07-10 Akita Univ Oil and fat composition and method for producing the same
JP2010001259A (en) * 2008-06-20 2010-01-07 Kao Corp Water-in-oil type emulsion cosmetic
JP2015017048A (en) * 2013-07-10 2015-01-29 日本メナード化粧品株式会社 Prevention and improvement agent for wrinkle formation on skin, hyaluronan production promoter, collagen production promoter and mmp inhibitor
US11547953B2 (en) 2018-03-16 2023-01-10 Ricoh Company, Ltd. Method of producing extract and extraction residue of biological material, extract, and extraction residue

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008156509A (en) * 2006-12-25 2008-07-10 Akita Univ Oil and fat composition and method for producing the same
JP2010001259A (en) * 2008-06-20 2010-01-07 Kao Corp Water-in-oil type emulsion cosmetic
JP2015017048A (en) * 2013-07-10 2015-01-29 日本メナード化粧品株式会社 Prevention and improvement agent for wrinkle formation on skin, hyaluronan production promoter, collagen production promoter and mmp inhibitor
US11547953B2 (en) 2018-03-16 2023-01-10 Ricoh Company, Ltd. Method of producing extract and extraction residue of biological material, extract, and extraction residue

Similar Documents

Publication Publication Date Title
PL202948B1 (en) Emulsion containing a plant extract, method for producing said emulsion and for obtaining a plant extract
JP5602346B2 (en) Preparation method of eucalyptus extract
JP4686173B2 (en) Processed acerola containing polyphenol and / or vitamin C
JPH04202138A (en) Hop extract having active oxygen scavenging action and its utilization
US7767236B2 (en) Plant seed extract composition and process for producing the same
JPH053453B2 (en)
JPH07119176B2 (en) Anti-active oxygen acting composition and anti-active oxygen agent containing the same as an active ingredient, food, cosmetics and pharmaceuticals
JP6778026B2 (en) Whitening agents and whitening foods and drinks containing 4&#39;-demethylnobiletin as an active ingredient
JP2001139945A (en) Antioxidant
JP2006169236A (en) Glycogenesis inhibitor
EP1715879A1 (en) Onion extracts
JP5138330B2 (en) Processed products of makomotake
JP3980952B2 (en) Enteric fat absorption inhibitor containing plant extract and food containing the same
JP2005350432A (en) Prostacyclin formation promoter
JPH06183987A (en) Lipoperoxide formation inhibitor and composition containing the same
WO2021153485A1 (en) Composition containing curcumin compound, and method for producing same
JP6806729B2 (en) An edible composition containing black soybean seed coat extract and long pepper extract as essential components for enhancing serum nitric oxide production, promoting improvement of antioxidant function in liver, and promoting function of lowering triglyceride content in serum. Vascular endothelial function improving agent
KR102040405B1 (en) Food Composition for Including Extracts of Tetragonia tetragonioides Having Anti-Obese and Preparation for Thereof
JPH0751510B2 (en) Anti-active oxygen agent and anti-active oxygen agent containing the same as an active ingredient, food, cosmetics and pharmaceuticals
KR102428082B1 (en) Cosmetic composition, pharmaceutical composition, and food composition comprising pterocaria stenoptera extract, which have anti-inflammatory immune activity and antioxidant activity and provide excellent effect on muscle cell generation for strengthening muscle strength or muscle in the elderly
JPS63295512A (en) Carcinostatic agent
JP2000044468A (en) Lipase inhibitor and antiobestic medicine or hyperlipidemia inhibitor
KR102069125B1 (en) Pharmaceutical composition for preventing or treating liver damage comprising Curcuma longa extract
JP2005170804A (en) Antiallergic agent
JP2022077501A (en) Skin external composition for promoting horny layer ceramide synthesis

Legal Events

Date Code Title Description
A300 Withdrawal of application because of no request for examination

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 20070206